Recommended Global Pathology Webinars & Conferences
Asia Pacific & Middle East
GYNECOLOGY AND OBSTETRICS 2027
About Conference
The 11th International Conference on Gynecology and Obstetrics Pathology, scheduled for February 25–26, 2027, in Amsterdam, Netherlands, will bring together leading pathologists, gynecologists, obstetricians, oncologists, researchers, academicians, and healthcare professionals from around the world. Under the theme "Advancing Pathology for Improved Maternal and Reproductive Health," the conference aims to promote scientific collaboration and knowledge exchange in the field of gynecologic and obstetric pathology.
The conference will feature keynote lectures, scientific presentations, panel discussions, poster sessions, and networking opportunities covering the latest advances in diagnostic pathology, molecular pathology, placental and fetal pathology, gynecologic cancers, reproductive pathology, digital pathology, precision medicine, and emerging technologies. Participants will have the opportunity to explore innovative research, share clinical experiences, and discuss evidence-based approaches that improve disease diagnosis, patient care, and maternal and reproductive health outcomes.
This international gathering provides an excellent platform for fostering interdisciplinary collaboration, encouraging innovation, and strengthening global partnerships to advance pathology and women's healthcare.
Target Audience
The 11th International Conference on Gynecology and Obstetrics Pathology welcomes professionals, researchers, and industry experts involved in women's health, pathology, and diagnostic sciences, including:
- Pathologists
- Gynecologists
- Obstetricians
- Oncologists
- Clinical Researchers
- Reproductive Medicine Specialists
- Medical Laboratory Professionals
- Academic Faculty and Scientists
- PhD Scholars and Medical Students
- Pharmaceutical, Biotechnology, and Medical Device Professionals
Why Attend?
- Learn about the latest developments in gynecology and obstetrics pathology.
- Gain insights from leading experts and researchers.
- Present your research through oral or poster presentations.
- Discover new diagnostic techniques and technologies.
- Network with healthcare professionals from around the world.
- Exchange ideas and collaborate with international experts.
- Explore advances in women's reproductive and maternal health.
- Enhance your professional knowledge and skills.
- Stay updated on current research and clinical practices.
- Build valuable academic and professional connections.
Sessions/Tracks
Gynecologic Pathology focuses on the study, diagnosis, and classification of diseases affecting the female reproductive system, including the cervix, uterus, ovaries, fallopian tubes, vulva, and vagina. It plays a vital role in identifying benign, premalignant, and malignant conditions through advanced histopathological evaluation and diagnostic techniques. Recent developments in immunohistochemistry, molecular testing, and tumor classification have significantly improved diagnostic accuracy and patient management. This area highlights the importance of multidisciplinary collaboration between pathologists, gynecologists, oncologists, and researchers to enhance disease understanding and treatment strategies. Advances in personalized medicine and precision diagnostics continue to transform the approach toward early detection, targeted therapies, and improved outcomes in women's health.
Obstetric Pathology focuses on pathological conditions associated with pregnancy, childbirth, and maternal-fetal health. It involves the evaluation of pregnancy-related disorders, maternal diseases, fetal complications, and abnormalities that may influence pregnancy outcomes. Understanding pathological changes during pregnancy is essential for identifying causes of complications such as pregnancy loss, preterm birth, fetal growth restriction, and maternal health challenges. Advances in diagnostic pathology, placental examination, and molecular investigations have improved the ability to understand complex obstetric conditions. This field promotes collaboration among obstetricians, pathologists, neonatologists, and researchers to develop effective diagnostic and preventive strategies. Improved knowledge of pregnancy-related pathology contributes to safer pregnancies, better fetal outcomes, and enhanced maternal healthcare worldwide.
Placental Pathology focuses on the examination of placental structure, function, and abnormalities that influence maternal and fetal health. The placenta plays a critical role in pregnancy by supporting fetal growth, nutrient exchange, and immune regulation. Pathological evaluation helps identify conditions such as placental insufficiency, infections, vascular disorders, inflammatory changes, and abnormalities associated with pregnancy complications. Detailed placental analysis provides valuable insights into causes of fetal growth restriction, preeclampsia, stillbirth, and recurrent pregnancy loss. Advances in histological techniques, molecular investigations, and diagnostic approaches have enhanced understanding of placental diseases. Collaboration among pathologists, obstetricians, and researchers supports improved pregnancy management, early diagnosis of complications, and development of strategies to promote healthier maternal and fetal outcomes.
Cervical Pathology focuses on the diagnosis and investigation of diseases affecting the cervix, including inflammatory conditions, precancerous changes, and cervical cancer. Human papillomavirus (HPV) infection plays a major role in cervical disease development, making accurate screening and early detection essential for prevention and treatment. Advances in cervical cytology, histopathology, immunohistochemistry, and molecular testing have improved diagnostic accuracy and risk assessment. This area explores modern approaches to identifying cervical lesions, understanding disease progression, and implementing effective management strategies. Research in biomarkers, HPV vaccination impact, and advanced screening technologies continues to transform cervical healthcare. Improved diagnostic methods and preventive strategies contribute significantly to reducing cervical cancer incidence and improving women's health outcomes globally.
Track 5: Endometrial Pathology
Endometrial Pathology focuses on disorders affecting the inner lining of the uterus, including hormonal changes, inflammatory conditions, hyperplasia, and endometrial cancers. Accurate evaluation of endometrial tissue is essential for diagnosing abnormal uterine bleeding, fertility-related issues, and malignant conditions. Recent advancements in molecular classification, immunohistochemistry, and genetic profiling have enhanced understanding of endometrial diseases and improved personalized treatment approaches. This area highlights the importance of identifying early pathological changes and distinguishing between benign and malignant conditions. Collaboration between pathologists, gynecologists, and oncologists supports better diagnostic decisions and patient care. Emerging research in biomarkers and precision medicine continues to improve the detection, classification, and management of endometrial disorders.
Ovarian Pathology focuses on the study and diagnosis of diseases affecting the ovaries, including benign lesions, borderline tumors, and ovarian cancers. Ovarian conditions often present diagnostic challenges due to their diverse biological behavior and complex classification. Advanced histopathological evaluation, molecular testing, and biomarker analysis have improved the identification and characterization of ovarian diseases. Understanding genetic alterations and tumor biology plays an important role in developing targeted treatment strategies and improving patient outcomes. This area emphasizes the importance of accurate diagnosis for guiding clinical decisions and selecting appropriate therapies. Research in ovarian cancer pathways, early detection methods, and personalized medicine continues to contribute to improved prevention, diagnosis, and management of ovarian disorders.
Track 7: Vulvar & Vaginal Pathology
Vulvar and Vaginal Pathology focuses on diseases affecting the external and internal female genital structures, including infections, inflammatory conditions, precancerous lesions, and malignancies. These conditions may significantly impact women's health, quality of life, and reproductive well-being. Accurate pathological evaluation helps differentiate between benign changes and serious disorders requiring further treatment. Advances in histology, molecular testing, and HPV-related research have improved understanding of vulvar and vaginal diseases. This area explores emerging diagnostic techniques, disease classification, and clinical approaches for effective management. Collaboration between pathologists, gynecologists, and researchers is essential for improving early detection and treatment outcomes. Continued research supports better awareness, prevention, and care for patients with vulvar and vaginal conditions.
Track 8: Fallopian Tube Pathology
Fallopian Tube Pathology focuses on the diagnosis and understanding of diseases affecting the fallopian tubes, including inflammatory disorders, infections, ectopic pregnancy-related changes, and rare malignant conditions. The fallopian tubes play an essential role in reproduction, making their health important for fertility and overall reproductive outcomes. Recent discoveries have highlighted the involvement of the fallopian tube in the development of certain ovarian cancers, increasing the importance of detailed pathological evaluation. Advanced microscopy, molecular techniques, and preventive strategies have improved disease detection and classification. This area emphasizes the role of pathology in identifying early changes, supporting clinical decision-making, and enhancing reproductive healthcare. Ongoing research continues to expand knowledge of tubal disorders and their impact on women's health.
Track 9: Gestational Pathology
Gestational Pathology focuses on pathological conditions associated with pregnancy-related tissues and processes. It includes the evaluation of gestational trophoblastic diseases, abnormal placental development, pregnancy complications, and disorders affecting maternal and fetal outcomes. Accurate diagnosis is essential for managing conditions such as molar pregnancy, abnormal implantation, and pregnancy-related tissue changes. Advances in histopathology, immunohistochemistry, and molecular analysis have improved the identification and classification of gestational disorders. This area supports collaboration between pathologists, obstetricians, and researchers to better understand pregnancy complications and improve patient care. Research into disease mechanisms, early diagnosis, and therapeutic approaches continues to enhance reproductive health management and contribute to safer pregnancy outcomes worldwide.
Breast Pathology focuses on the diagnosis and characterization of breast diseases, including benign lesions, inflammatory conditions, and breast cancers affecting women's health. Accurate pathological assessment plays a crucial role in determining disease type, severity, molecular characteristics, and appropriate treatment strategies. Advances in immunohistochemistry, genetic profiling, and molecular classification have transformed breast cancer diagnosis and personalized treatment approaches. This area explores innovative diagnostic methods, biomarkers, and emerging technologies that improve early detection and patient outcomes. Collaboration among pathologists, oncologists, surgeons, and researchers supports comprehensive breast healthcare. Continued research in tumor biology, precision medicine, and targeted therapies contributes to better prevention, diagnosis, and management of breast-related diseases.
Molecular Pathology focuses on the study of genetic, molecular, and cellular changes involved in gynecological and obstetric diseases. It combines traditional pathological evaluation with advanced molecular techniques to improve disease classification, diagnosis, prognosis, and treatment planning. Molecular testing helps identify genetic alterations, biomarkers, and disease-specific patterns that support personalized healthcare approaches. In gynecologic oncology, molecular profiling has enhanced understanding of ovarian, cervical, and endometrial cancers, enabling targeted therapies and improved patient outcomes. This area also explores emerging technologies such as next-generation sequencing, genomic analysis, and precision diagnostics. Collaboration between pathologists, researchers, and clinicians continues to advance the role of molecular medicine in improving diagnosis, treatment selection, and women’s health management.
Track 12: Gynecologic Cytopathology
Gynecologic Cytopathology focuses on the examination of cellular samples to detect and diagnose diseases affecting the female reproductive system. It plays a vital role in cervical cancer screening, early detection of abnormal cellular changes, and monitoring disease progression. Advances in liquid-based cytology, HPV testing, digital imaging, and automated screening technologies have improved diagnostic accuracy and efficiency. This area explores the importance of cytological evaluation in identifying precancerous lesions and supporting timely clinical interventions. Research in biomarkers, artificial intelligence, and advanced diagnostic methods continues to enhance the effectiveness of cytopathology. Collaboration between cytologists, pathologists, gynecologists, and researchers helps strengthen screening programs and contributes to reducing the global burden of gynecologic cancers.
Track 13: Reproductive Pathology
Reproductive Pathology focuses on pathological conditions that influence fertility, conception, implantation, and reproductive health. It includes the evaluation of abnormalities affecting reproductive organs, infertility-related conditions, implantation disorders, and tissue changes associated with reproductive challenges. Accurate pathological assessment provides important insights into the causes of infertility and supports effective clinical management. Advances in histological analysis, molecular diagnostics, and reproductive medicine have improved understanding of complex fertility-related disorders. This area highlights collaboration between pathologists, reproductive specialists, and researchers to develop innovative diagnostic approaches. Emerging research in embryo implantation, endometrial health, and reproductive biomarkers continues to enhance fertility care and improve outcomes for individuals seeking reproductive assistance.
Fetal Pathology focuses on the examination of fetal abnormalities, developmental disorders, and conditions affecting fetal health during pregnancy. It plays an important role in understanding causes of fetal loss, congenital abnormalities, genetic disorders, and developmental complications. Detailed fetal examination provides valuable information for diagnosis, counseling, and future pregnancy planning. Advances in genetic testing, imaging technologies, molecular analysis, and prenatal diagnostics have significantly improved the understanding of fetal diseases. This area encourages collaboration among pathologists, obstetricians, geneticists, and researchers to improve prenatal care and maternal counseling. Continued research in fetal development, congenital disorders, and advanced diagnostic methods contributes to better pregnancy management and improved outcomes for mothers and babies.
Prenatal Pathology focuses on the identification and evaluation of abnormalities occurring before birth through advanced diagnostic approaches. It includes the study of fetal conditions, genetic abnormalities, placental disorders, and pregnancy-related complications that may affect maternal and fetal health. Early detection through prenatal screening, molecular testing, and pathological assessment supports informed clinical decisions and improved pregnancy management. This area highlights advances in non-invasive prenatal testing, genetic analysis, and fetal diagnostic techniques. Collaboration among pathologists, obstetricians, genetic counselors, and researchers plays a key role in improving prenatal healthcare. Ongoing innovations continue to enhance early diagnosis, risk assessment, and personalized approaches to support healthier pregnancies and better neonatal outcomes.
Track 16: Infectious Pathology
Infectious Pathology focuses on the study of infections affecting the female reproductive system, pregnancy, and maternal-fetal health. It includes bacterial, viral, fungal, and parasitic infections that may influence fertility, pregnancy outcomes, and newborn health. Accurate pathological evaluation helps identify infection-related tissue changes and supports appropriate treatment strategies. Advances in molecular diagnostics, microbiological testing, and immunological methods have improved detection and understanding of infectious diseases. This area explores the impact of infections such as HPV, sexually transmitted infections, and pregnancy-associated infections. Collaboration between pathologists, infectious disease specialists, and obstetricians supports effective prevention, diagnosis, and management. Research continues to improve strategies for protecting maternal health and reducing infection-related complications.
Track 17: Endometriosis Pathology
Endometriosis Pathology focuses on the study of endometriosis, a chronic condition characterized by the presence of endometrial-like tissue outside the uterus. It examines the pathological changes associated with inflammation, fibrosis, pain, infertility, and disease progression. Accurate diagnosis through histological evaluation is essential for effective management and treatment planning. Advances in molecular research have improved understanding of the biological mechanisms involved in endometriosis development and progression. This area explores emerging biomarkers, diagnostic techniques, and therapeutic approaches aimed at improving patient outcomes. Collaboration among pathologists, gynecologists, and researchers contributes to better recognition and management of this complex condition. Continued research supports improved diagnosis, personalized treatment, and enhanced quality of life for affected individuals.
Digital Pathology focuses on the integration of advanced digital technologies, artificial intelligence, and computational tools into pathological diagnosis and research. It enables the conversion of traditional tissue analysis into digital formats, allowing improved visualization, data sharing, and remote collaboration. In gynecology and obstetrics pathology, digital approaches support accurate diagnosis, research development, and efficient workflow management. Artificial intelligence-based image analysis assists in identifying patterns, improving diagnostic consistency, and supporting clinical decision-making. This area explores innovations in machine learning, automated analysis, and digital healthcare solutions. Collaboration between pathologists, technology experts, and researchers continues to transform modern pathology practices and enhance the quality, speed, and accessibility of diagnostic services worldwide.
Precision Pathology focuses on personalized diagnostic approaches that integrate molecular information, biomarkers, and advanced technologies to support individualized patient care. It aims to provide accurate disease classification and guide targeted treatment strategies based on specific biological characteristics. In gynecologic and obstetric conditions, precision pathology contributes to improved understanding of cancers, reproductive disorders, and complex diseases. Advances in genomic testing, molecular profiling, and biomarker discovery have expanded opportunities for personalized healthcare. This area emphasizes collaboration between pathologists, clinicians, researchers, and healthcare professionals to develop innovative diagnostic solutions. Continued progress in precision medicine is transforming disease management by improving treatment selection, predicting outcomes, and supporting better healthcare decisions for women worldwide.
Track 20: Emerging Trends in Pathology
Emerging Trends in Pathology focuses on the latest innovations, research developments, and future directions shaping modern gynecology and obstetrics pathology. Rapid advancements in artificial intelligence, molecular diagnostics, digital technologies, and precision medicine are transforming disease detection and patient care. New approaches in biomarker discovery, genomic analysis, and automated diagnostic systems are improving accuracy and efficiency in pathology practices. This area highlights innovative research, technological breakthroughs, and evolving clinical applications that support better understanding and management of women’s health conditions. Collaboration among global experts, researchers, and healthcare professionals encourages knowledge exchange and promotes future advancements. Continued innovation will play a key role in improving diagnosis, treatment strategies, and healthcare outcomes in gynecology and obstetrics pathology.
Market Analysis
The global women’s health market has witnessed strong growth over the past decade, driven by increasing awareness of reproductive health, rising prevalence of gynecological disorders, and advancements in diagnostic technologies. The global women’s health market was valued at approximately USD 60–70 billion in 2022 and is projected to reach over USD 100 billion by 2030, growing at a CAGR of around 6–8% from 2023 to 2030. The gynecology and obstetrics pathology sector is expanding due to the increasing demand for early diagnosis and management of conditions such as cervical cancer, ovarian cancer, endometrial disorders, infertility, and pregnancy-related complications.
The adoption of advanced diagnostic technologies has accelerated significantly between 2023 and 2030, particularly in areas such as molecular pathology, digital pathology, artificial intelligence (AI), and precision medicine. The global digital pathology market was valued at approximately USD 1 billion in 2022 and is expected to surpass USD 3–4 billion by 2030, registering a CAGR of more than 10–12% during 2023–2030. Similarly, molecular diagnostics and genomic testing are projected to grow at approximately 8–10% CAGR from 2024 to 2030, supported by increasing demand for personalized treatment approaches and biomarker-based disease detection in gynecologic oncology.
From 2025 to 2035, the gynecology and obstetrics pathology field is expected to experience continued expansion due to rising healthcare investments, improved cancer screening programs, and growing focus on maternal and reproductive health worldwide. Europe remains a significant contributor due to advanced healthcare infrastructure, research capabilities, and adoption of innovative pathology solutions. Emerging technologies, including AI-assisted diagnosis, next-generation sequencing, and automated pathology systems, are expected to create new opportunities, with the overall women’s healthcare and diagnostic sector projected to maintain steady growth of approximately 6–10% annually through 2035.
To Collaborate Scientific Professionals around the World
Conference Date February 25-26, 2027
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Past Conference Report
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by